Emergent Biosolutions EBS Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's operating lease liabilities (current)?
- Emergent Biosolutions (EBS) reported operating lease liabilities (current) of $2.4M in Q1 2026.
- How has Emergent Biosolutions's operating lease liabilities (current) changed year-over-year?
- Emergent Biosolutions's operating lease liabilities (current) increased by 26.3% year-over-year, from $1.9M to $2.4M.
- What is the long-term trend for Emergent Biosolutions's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Emergent Biosolutions's operating lease liabilities (current) has grown at a -15.0% compound annual growth rate (CAGR), from $5.4M to $2.4M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.